Immutep's Acquisition

Immutep was acquired by Immutep on October 02, 2014.

Immutep is a late stage privately owned biopharmaceutical company in the rapidly growing field of immuno-oncology. Immutep has been developing a number of complementary types of cancer immunotherapies…

Articles about Immutep's Acquisition: